Insulet Corp. (PODD)
287.36
-1.27
(-0.44%)
USD |
NASDAQ |
Dec 29, 16:00
287.35
-0.01
(-0.00%)
After-Hours: 20:00
Insulet EPS Diluted (Quarterly): 1.240 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | -0.3128 |
| Boston Scientific Corp. | 0.5048 |
| Intuitive Surgical, Inc. | 1.947 |
| Abbott Laboratories | 0.9146 |
| Globus Medical, Inc. | 0.8787 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 87.60M |
| Revenue (Quarterly) | 706.30M |
| Total Expenses (Quarterly) | 618.70M |
| Enterprise Value | 20.49B |
| Gross Profit Margin (Quarterly) | 72.70% |
| Profit Margin (Quarterly) | 12.40% |
| Earnings Yield | 1.20% |
| Operating Earnings Yield | 2.10% |
| Normalized Earnings Yield | 1.610 |